If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Peter Gæde is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles
Type 2 Diabetes Mellitus Medicine & Life Sciences
Kidney Medicine & Life Sciences
Diabetic Nephropathies Medicine & Life Sciences
Hydroxymethylglutaryl-CoA Reductase Inhibitors Medicine & Life Sciences
Albuminuria Medicine & Life Sciences
Glomerular Filtration Rate Medicine & Life Sciences
Albumins Medicine & Life Sciences
Cost-Benefit Analysis Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1993 2019

60 Downloads (Pure)

A cost analysis of intensified vs conventional multifactorial therapy in individuals with type 2 diabetes: a post hoc analysis of the Steno-2 study

Gæde, J., Oellgaard, J., Ibsen, R., Gæde, P., Nørtoft, E., Parving, H. H., Kjellberg, J. & Pedersen, O., Jan 2019, In : Diabetologia. 62, 1, p. 147-155

Research output: Contribution to journalJournal articleResearchpeer-review

Open Access
File
Type 2 Diabetes Mellitus
Insurance Benefits
Cost-Benefit Analysis
Registries
Inpatients

Beneficial impact of intensified multifactorial intervention on risk of stroke: outcome of 21 years of follow-up in the randomised Steno-2 Study

Gæde, P., Oellgaard, J., Kruuse, C., Rossing, P., Parving, H. H. & Pedersen, O., Sep 2019, In : Diabetologia. 62, 9, p. 1575-1580

Research output: Contribution to journalJournal articleResearchpeer-review

Open Access
Type 2 Diabetes Mellitus
Epidemiologic Studies

Cardiac perfusion, structure, and function in type 2 diabetes mellitus with and without diabetic complications

Sørensen, M. H., Bojer, A. S., Broadbent, D. A., Plein, S., Madsen, P. L. & Gæde, P., 23. Oct 2019, In : European Heart Journal Cardiovascular Imaging.

Research output: Contribution to journalJournal articleResearchpeer-review

Diabetes Complications
Type 2 Diabetes Mellitus
Perfusion
Albuminuria
Left Ventricular Function

Correction to: Management of Patients with Type 2 Diabetes with Once-Weekly Semaglutide Versus Dulaglutide, Exenatide ER, Liraglutide and Lixisenatide: A Cost-Effectiveness Analysis in the Danish Setting (Diabetes Therapy, (2019), 10.1007/s13300-019-0630-6)

Gæde, P., Johansen, P., Tikkanen, C. K., Pollock, R. F., Hunt, B. & Malkin, S. J. P., Aug 2019, In : Diabetes Therapy. 10, 4, p. 1319-1321

Research output: Contribution to journalComment/debateResearchpeer-review

Open Access
Quality-Adjusted Life Years
Type 2 Diabetes Mellitus
Cost-Benefit Analysis
Publications
ZP10A peptide
Open Access
Inferior Vena Cava
Physiologic Monitoring
Lung
Point-of-Care Systems
Hospital Departments

Activities 2016 2019

  • 4 Conference presentations

Reduced myocardial perfusion reserve in type 2 diabetes is caused by increased rest perfusion as well as decreased maximal perfusion during stress

Martin Heyn Sørensen (Guest lecturer), Annemie Stege Bojer (Other), Per Lav Madsen (Other), Peter Gæde (Other)
2. Sep 2019

Activity: Talks and presentationsConference presentations

Myocardial perfusion reserve index in type 2 diabetes as determined by cardiac magnetic resonance imaging

Martin Heyn Sørensen (Lecturer), Annemie Stege Bojer (Other), Per Lav Madsen (Other), Peter Gæde (Other)
28. Aug 2018

Activity: Talks and presentationsConference presentations

Myocardial perfusion reserve index hos patienter med type 2 diabetes med og uden komplikationer og raske kontroller

Martin Heyn Sørensen (Lecturer), Annemie Stege Bojer (Other), Per Lav Madsen (Other), Peter Gæde (Other)
4. May 2018

Activity: Talks and presentationsConference presentations

cardiac magnetic resonance imaging in type 2 diabetes mellitus. On the mechanisms of cardiac function and perfusion dysfunction

Martin Heyn Sørensen (Lecturer), Annemie Stege Bojer (Other), Per Lav Madsen (Other), Peter Gæde (Other)
25. Mar 2016

Activity: Talks and presentationsConference presentations